Zentalis Pharmaceuticals (ZNTL) Depreciation & Amortization (CF) (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Depreciation & Amortization (CF) came in at $151000.0 in Q1 2026, down 42.37% year-on-year from $262000.0 in Q1 2025, and up 27.97% quarter-over-quarter from $118000.0 in Q4 2025.
Zentalis Pharmaceuticals has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $151000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 42.37% year-over-year to $151000.0; the trailing twelve-month figure through Mar 2026 stood at $589000.0 (down 52.0% YoY), and the FY2025 full-year result was $700000.0, down 45.69% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $151000.0, up from $118000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $375000.0 in Q3 2022, with the low at $118000.0 in Q4 2025.
- Average Depreciation & Amortization (CF) over 5 years is $292117.6, with a median of $327000.0 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) soared 335.44% in 2022 and slumped 62.78% in 2025.
- Tracing ZNTL's Depreciation & Amortization (CF) over 5 years: stood at $359000.0 in 2022, then decreased by 3.06% to $348000.0 in 2023, then decreased by 8.91% to $317000.0 in 2024, then tumbled by 62.78% to $118000.0 in 2025, then increased by 27.97% to $151000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $151000.0 (Q1 2026), $118000.0 (Q4 2025), and $160000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | 151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Dec 31, 2024 | 317,000.00 |
| Dec 31, 2024 | 317,000.00 |
| Sep 30, 2024 | 321,000.00 |
| Sep 30, 2024 | 321,000.00 |
| Jun 30, 2024 | 327,000.00 |
| Jun 30, 2024 | 327,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 348,000.00 |
| Sep 30, 2023 | 348,000.00 |
| Jun 30, 2023 | 344,000.00 |
| Jun 30, 2023 | 344,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Jun 30, 2022 | 348,000.00 |
| Mar 31, 2022 | 344,000.00 |
| Mar 31, 2022 | 344,000.00 |
| Dec 31, 2021 | 165,000.00 |
| Dec 31, 2021 | 165,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 119,000.00 |
| Jun 30, 2021 | 119,000.00 |
| Mar 31, 2021 | 79,000.00 |
| Mar 31, 2021 | 79,000.00 |
| Dec 31, 2020 | 33,000.00 |
| Dec 31, 2020 | 33,000.00 |
| Sep 30, 2020 | 51,000.00 |
| Sep 30, 2020 | 51,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Dec 31, 2019 | 41,000.00 |
| Dec 31, 2019 | 41,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Jun 30, 2019 | 24,000.00 |
| Jun 30, 2019 | 24,000.00 |
| Mar 31, 2019 | 21,000.00 |
| Mar 31, 2019 | 21,000.00 |